These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 36017393)

  • 21. A scoping review of active, participant-centred, digital adverse events following immunization (AEFI) surveillance: A Canadian immunization research network study.
    Psihogios A; Brianne Bota A; Mithani SS; Greyson D; Zhu DT; Fung SG; Wilson SE; Fell DB; Top KA; Bettinger JA; Wilson K
    Vaccine; 2022 Jul; 40(31):4065-4080. PubMed ID: 35680501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of adverse effects following immunisation degree after the administration COVID-19 vaccine of different platforms.
    Bermawi B; Donastin A; Sari NDK; Kurniasari DW; Adriansyah AA; Ferdiansyah MA; Rofananda IF; Surya PA
    Med J Malaysia; 2024 Mar; 79(2):124-127. PubMed ID: 38553914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India.
    Joshi J; Das MK; Polpakara D; Aneja S; Agarwal M; Arora NK
    Indian J Pediatr; 2018 Feb; 85(2):139-148. PubMed ID: 29170922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serious adverse event following immunization and thromboembolic events associated with COVID19 vaccination: An analysis of nationwide causality assessment from India.
    Gandhi AP; Venkatesh U; Murali N
    Indian Heart J; 2023; 75(2):139-144. PubMed ID: 36863611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
    Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
    Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials.
    Chen M; Yuan Y; Zhou Y; Deng Z; Zhao J; Feng F; Zou H; Sun C
    Infect Dis Poverty; 2021 Jul; 10(1):94. PubMed ID: 34225791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leveraging COVID-19 Vaccine Safety Monitoring in Ethiopia and Pakistan to Enhance System-Wide Safety Surveillance.
    Hagos AA; Sahile Z; Ahmed W; Phanouvong S
    Glob Health Sci Pract; 2024 Feb; 12(Suppl 1):. PubMed ID: 38216210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immediate adverse events following COVID-19 immunization. A cross-sectional study of 314,664 Italian subjects.
    Gianfredi V; Minerva M; Casu G; Capraro M; Chiecca G; Gaetti G; Mantecca Mazzocchi R; Musarò P; Berardinelli P; Basteri P; Bertini B; Ferri C; Odone A; Signorelli C; Alberti VF; Gastaldi G
    Acta Biomed; 2021 Oct; 92(S6):e2021487. PubMed ID: 34739452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature.
    Duijster JW; Lieber T; Pacelli S; Van Balveren L; Ruijs LS; Raethke M; Kant A; Van Hunsel F
    Front Immunol; 2023; 14():1078736. PubMed ID: 36793715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse event following immunization (AEFI) surveillance in India, position paper of Indian Academy of Pediatrics,2013.
    Chitkara AJ; Thacker N; Vashishtha VM; Bansal CP; Gupta SG
    Indian Pediatr; 2013 Aug; 50(8):739-41. PubMed ID: 24036641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse events following immunization against SARS-CoV-2 (covid-19) in the state of Minas Gerais.
    Silva RBD; Silva TPRD; Sato APS; Lana FCF; Gusmão JD; Souza JFA; Matozinhos FP
    Rev Saude Publica; 2021; 55():66. PubMed ID: 34706042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying adverse events of vaccines using a Bayesian method of medically guided information sharing.
    Crooks CJ; Prieto-Merino D; Evans SJ
    Drug Saf; 2012 Jan; 35(1):61-78. PubMed ID: 22136183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance for adverse events following immunization from 2008 to 2011 in Zhejiang Province, China.
    Hu Y; Li Q; Lin L; Chen E; Chen Y; Qi X
    Clin Vaccine Immunol; 2013 Feb; 20(2):211-7. PubMed ID: 23239804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using FHIR to Support COVID-19 Vaccine Safety Electronic Case Reports in America.
    Rizzato Lede DA; Molina HF; Bertoglia MP; Otzoy D; Benavides LA; Donis JA; Osorio VB; Aguilar C; Bustos JL; Diaz M; Revirol K; Galindo C; Mansilla J; Campos F; Kaminker D; D'agostino M; Pastor D
    Stud Health Technol Inform; 2022 May; 294():694-698. PubMed ID: 35612178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China.
    Guo B; Page A; Wang H; Taylor R; McIntyre P
    Vaccine; 2013 Jan; 31(4):603-17. PubMed ID: 23200940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse events following immunization: real causality and myths.
    Principi N; Esposito S
    Expert Opin Drug Saf; 2016 Jun; 15(6):825-35. PubMed ID: 26986067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 vaccine safety inquiries to the centers for disease control and prevention immunization safety office.
    Miller ER; Moro PL; Shimabukuro TT; Carlock G; Davis SN; Freeborn EM; Roberts AL; Gee J; Taylor AW; Gallego R; Suragh T; Su JR
    Vaccine; 2023 Jun; 41(27):3960-3963. PubMed ID: 37248099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seizures after vaccines.
    Lakhoua G; Daly W; Charfi O; Zaiem A; Aouinti I; Kastalli S; Daghfous R; El Aidli S
    Therapie; 2022; 77(6):657-661. PubMed ID: 35599195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.